RT Journal Article
SR Electronic
T1 Mapping physical access to healthcare for older adults in sub-Saharan Africa: A cross-sectional analysis with implications for the COVID-19 response
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.17.20152389
DO 10.1101/2020.07.17.20152389
A1 Geldsetzer, Pascal
A1 Reinmuth, Marcel
A1 Ouma, Paul O.
A1 Lautenbach, Sven
A1 Okiro, Emelda A.
A1 Bärnighausen, Till
A1 Zipf, Alexander
YR 2020
UL http://medrxiv.org/content/early/2020/08/26/2020.07.17.20152389.abstract
AB Background SARS-CoV-2, the virus causing coronavirus disease 2019 (COVID-19), is rapidly spreading across sub-Saharan Africa (SSA). Hospital-based care for COVID-19 is particularly often needed among older adults. However, a key barrier to accessing hospital care in SSA is travel time to the healthcare facility. To inform the geographic targeting of additional healthcare resources, this study aimed to determine the estimated travel time at a 1km x 1km resolution to the nearest hospital and to the nearest healthcare facility of any type for adults aged 60 years and older in SSA.Methods We assembled a unique dataset on healthcare facilities’ geolocation, separately for hospitals and any type of healthcare facility (including primary care facilities) and including both private- and public-sector facilities, using data from the OpenStreetMap project and the KEMRI Wellcome Trust Programme. Population data at a 1km x 1km resolution was obtained from WorldPop. We estimated travel time to the nearest healthcare facility for each 1km x 1km grid using a cost-distance algorithm.Findings 9.6% (95% CI: 5.2% – 16.9%) of adults aged ≥60 years had an estimated travel time to the nearest hospital of longer than six hours, varying from 0.0% (95% CI: 0.0% – 3.7%) in Burundi and The Gambia, to 40.9% (95% CI: 31.8% – 50.7%) in Sudan. 11.2% (95% CI: 6.4% – 18.9%) of adults aged ≥60 years had an estimated travel time to the nearest healthcare facility of any type (whether primary or secondary/tertiary care) of longer than three hours, with a range of 0.1% (95% CI: 0.0% – 3.8%) in Burundi to 55.5% (95% CI: 52.8% – 64.9%) in Sudan. Most countries in SSA contained populated areas in which adults aged 60 years and older had a travel time to the nearest hospital of more than 12 hours and to the nearest healthcare facility of any type of more than six hours. The median travel time to the nearest hospital for the fifth of adults aged ≥60 years with the longest travel times was 348 minutes (equal to 5.8 hours; IQR: 240 – 576 minutes) for the entire SSA population, ranging from 41 minutes (IQR: 34 – 54 minutes) in Burundi to 1,655 minutes (equal to 27.6 hours; IQR: 1065 – 2440 minutes) in Gabon.Interpretation Our high-resolution maps of estimated travel times to both hospitals and healthcare facilities of any type can be used by policymakers and non-governmental organizations to help target additional healthcare resources, such as new make-shift hospitals or transport programs to existing healthcare facilities, to older adults with the least physical access to care. In addition, this analysis shows precisely where population groups are located that are particularly likely to under-report COVID-19 symptoms because of low physical access to healthcare facilities. Beyond the COVID-19 response, this study can inform countries’ efforts to improve care for conditions that are common among older adults, such as chronic non-communicable diseases.Funding Bill & Melinda Gates FoundationEvidence before this study We searched MEDLINE from January 1966 until May 2020 for studies with variations of the words ‘physical access’, ‘distance’, ‘travel time’, ‘hospital’, and ‘healthcare facility’ in the title or abstract. To date, the only studies to systematically map physical access to healthcare facilities in sub-Saharan Africa at a high resolution examined access to emergency hospital care (with a focus on women of child-bearing age), access to care for children with fever, travel time to the nearest healthcare facility for specific populations at risk of viral haemorrhagic fevers, and travel time to the nearest regional- or district-level hospital.Added value of this study The added value of this study is threefold. First, we assembled a new dataset of GPS-tagged healthcare facilities, which combines two unique data sources for the geolocation of healthcare facilities across sub-Saharan Africa: one-based on crowd-sourced data from OpenStreetMap and one based on information from ministries of health, health management information systems, government statistical agencies, and international organizations. Second, this is the first study to comprehensively map both hospitals and primary healthcare facilities, and including both public- and private-sector facilities, across sub-Saharan Africa. Third, because the COVID-19 epidemic causes a far higher need for hospital services among older than younger population groups, we focus on physical access to healthcare for the population aged 60 years and older, which is a population group that is rarely studied in investigations of healthcare demand and supply in the region. As such, our maps can inform not only the health system response to COVID-19, but more generally to conditions that are common among older adults in the region, particularly chronic non-communicable diseases and their sequelae.Implications of all the available evidence Low physical access to healthcare in sub-Saharan Africa will be a major barrier to receiving care for adults aged 60 years and older with COVID-19. However, there is a wide degree of variation in physical access to healthcare facilities for older adults in the region both between and within countries, which likely has an important bearing on the extent to which different population groups within countries are able to access care for COVID-19. Likewise, in those areas with a long travel time to the nearest healthcare facility of any type (which exist in most countries), symptomatic cases of COVID-19 are particularly unlikely to be reported to the healthcare system. Our high-resolution maps for each region and country in sub-Saharan Africa provide precise information about this geographic variation for local, national, and regional policymakers as well as non-governmental organizations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Klaus Tschira Foundation and the Bill & Melinda Gates Foundation (Agreement number: INV-016002). PG was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR003143. POO is funded under the IDeAL's Project, DELTAS Africa Initiative [DEL-15-003]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [number 107769/Z/10/Z] and the UK government. POO is also supported by funds provided under Professor RW Snow's Wellcome Trust Principal Fellowship (#'s 103602 & 212176). EAO is supported as Wellcome Trust Intermediate Fellow (number 201866); POO and EAO, acknowledge the support of the Wellcome Trust to the Kenya Major Overseas Programme (# 203077). The views expressed in this publication are those of the authors and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No patient data was used in this analysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are openly available in heiData at https://doi.org/10.11588/data/RGM2AW. https://doi.org/10.11588/data/RGM2AW